M7T Stock Overview
Provides enterprise imaging data sharing, storage, and interoperability for healthcare enterprises in North America, the Asia Pacific, the Middle East, Europe and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Mach7 Technologies Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.56 |
| 52 Week High | AU$0.81 |
| 52 Week Low | AU$0.55 |
| Beta | 1.67 |
| 11 Month Change | -5.08% |
| 3 Month Change | -14.50% |
| 1 Year Change | -25.83% |
| 33 Year Change | -42.86% |
| 5 Year Change | -13.18% |
| Change since IPO | -11.11% |
Recent News & Updates
Recent updates
Investors Interested In Mach7 Technologies Limited's (ASX:M7T) Revenues
Aug 01
Mach7 Technologies Limited (ASX:M7T) Analysts Are More Bearish Than They Used To Be
Jan 29Mach7 Technologies (ASX:M7T) Is In A Strong Position To Grow Its Business
Nov 23Is Now The Time To Look At Buying Mach7 Technologies Limited (ASX:M7T)?
Sep 29Estimating The Fair Value Of Mach7 Technologies Limited (ASX:M7T)
Sep 04Why Mach7 Technologies Limited (ASX:M7T) Could Be Worth Watching
Jun 13We're Interested To See How Mach7 Technologies (ASX:M7T) Uses Its Cash Hoard To Grow
Apr 28An Intrinsic Calculation For Mach7 Technologies Limited (ASX:M7T) Suggests It's 47% Undervalued
Oct 24Are Investors Undervaluing Mach7 Technologies Limited (ASX:M7T) By 37%?
Jun 23Is Mach7 Technologies Limited (ASX:M7T) Potentially Undervalued?
May 19Is There An Opportunity With Mach7 Technologies Limited's (ASX:M7T) 47% Undervaluation?
Nov 10Mach7 Technologies Limited's (ASX:M7T) Analyst Just Slashed This Year's Estimates
Jul 27Upgrade: The Latest Revenue Forecasts For Mach7 Technologies Limited (ASX:M7T)
Feb 19
The Mach7 Technologies (ASX:M7T) Share Price Is Up 303% And Shareholders Are Delighted
Jan 27Is There An Opportunity With Mach7 Technologies Limited's (ASX:M7T) 46% Undervaluation?
Dec 06Shareholder Returns
| M7T | AU Healthcare Services | AU Market | |
|---|---|---|---|
| 7D | -4.3% | -0.8% | 1.1% |
| 1Y | -25.8% | 84.9% | 11.4% |
Return vs Industry: M7T underperformed the Australian Healthcare Services industry which returned 84.9% over the past year.
Return vs Market: M7T underperformed the Australian Market which returned 11.4% over the past year.
Price Volatility
| M7T volatility | |
|---|---|
| M7T Average Weekly Movement | 4.7% |
| Healthcare Services Industry Average Movement | 7.9% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in AU Market | 17.2% |
| 10% least volatile stocks in AU Market | 3.5% |
Stable Share Price: M7T has not had significant price volatility in the past 3 months.
Volatility Over Time: M7T's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | n/a | Mike Lampron | www.mach7t.com |
Mach7 Technologies Limited provides enterprise imaging data sharing, storage, and interoperability for healthcare enterprises in North America, the Asia Pacific, the Middle East, Europe and internationally. The company offers enterprise diagnostic viewing, which includes eUnity zero-footprint viewer that connects departmental imaging from across the enterprise to deliver studies to care providers via the EMR. It also offers enterprise data management solutions that enable cross-department and cross-enterprise workflows to capture, index, manage, store, distribute, view, exchange, and analyze clinical imaging and multimedia content.
Mach7 Technologies Limited Fundamentals Summary
| M7T fundamental statistics | |
|---|---|
| Market cap | AU$135.09m |
| Earnings (TTM) | -AU$7.97m |
| Revenue (TTM) | AU$30.01m |
4.5x
P/S Ratio-16.9x
P/E RatioIs M7T overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| M7T income statement (TTM) | |
|---|---|
| Revenue | AU$30.01m |
| Cost of Revenue | AU$24.79m |
| Gross Profit | AU$5.22m |
| Other Expenses | AU$13.19m |
| Earnings | -AU$7.97m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.033 |
| Gross Margin | 17.39% |
| Net Profit Margin | -26.56% |
| Debt/Equity Ratio | 0% |
How did M7T perform over the long term?
See historical performance and comparison